152 related articles for article (PubMed ID: 8274012)
1. Enzyme-kinetic and immunochemical characteristics of mouse cDNA-expressed, microsomal, and purified CYP1A1 and CYP1A2.
Tsyrlov IB; Goldfarb IS; Gelboin HV
Arch Biochem Biophys; 1993 Dec; 307(2):259-66. PubMed ID: 8274012
[TBL] [Abstract][Full Text] [Related]
2. The alkaloid rutaecarpine is a selective inhibitor of cytochrome P450 1A in mouse and human liver microsomes.
Ueng YF; Jan WC; Lin LC; Chen TL; Guengerich FP; Chen CF
Drug Metab Dispos; 2002 Mar; 30(3):349-53. PubMed ID: 11854157
[TBL] [Abstract][Full Text] [Related]
3. [O-methyl 14C]naproxen O-demethylase activity in human liver microsomes: evidence for the involvement of cytochrome P4501A2 and P4502C9/10.
Rodrigues AD; Kukulka MJ; Roberts EM; Ouellet D; Rodgers TR
Drug Metab Dispos; 1996 Jan; 24(1):126-36. PubMed ID: 8825200
[TBL] [Abstract][Full Text] [Related]
4. Constitutive and inducible levels of CYP1A1 and CYP1A2 in rat cerebral cortex and cerebellum.
Iba MM; Storch A; Ghosal A; Bennett S; Reuhl KR; Lowndes HE
Arch Toxicol; 2003 Oct; 77(10):547-54. PubMed ID: 14574441
[TBL] [Abstract][Full Text] [Related]
5. Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2.
Tassaneeyakul W; Birkett DJ; Veronese ME; McManus ME; Tukey RH; Quattrochi LC; Gelboin HV; Miners JO
J Pharmacol Exp Ther; 1993 Apr; 265(1):401-7. PubMed ID: 8474022
[TBL] [Abstract][Full Text] [Related]
6. Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver.
Burke MD; Thompson S; Weaver RJ; Wolf CR; Mayer RT
Biochem Pharmacol; 1994 Aug; 48(5):923-36. PubMed ID: 8093105
[TBL] [Abstract][Full Text] [Related]
7. Effect of sulfur dioxide inhalation on CYP1A1 and CYP1A2 in rat liver and lung.
Qin G; Meng Z
Toxicol Lett; 2005 Dec; 160(1):34-42. PubMed ID: 16023800
[TBL] [Abstract][Full Text] [Related]
8. Molecular cloning and functional analysis of cytochrome P450 1A2 from Japanese monkey liver: comparison with marmoset cytochrome P450 1A2.
Narimatsu S; Oda M; Hichiya H; Isobe T; Asaoka K; Hanioka N; Yamano S; Shinoda S; Yamamoto S
Chem Biol Interact; 2005 Feb; 152(1):1-12. PubMed ID: 15766918
[TBL] [Abstract][Full Text] [Related]
9. Further immunochemical and biocatalytic characterization of CYP1A1 from feral leaping mullet liver (Liza saliens) microsomes.
Sen A; Arinç E
Comp Biochem Physiol C Toxicol Pharmacol; 2000 Jul; 126(3):235-44. PubMed ID: 11048673
[TBL] [Abstract][Full Text] [Related]
10. Contribution of CYP1A1 and CYP1A2 to the activation of heterocyclic amines in monkeys and human.
Edwards RJ; Murray BP; Murray S; Schulz T; Neubert D; Gant TW; Thorgeirsson SS; Boobis AR; Davies DS
Carcinogenesis; 1994 May; 15(5):829-36. PubMed ID: 8200083
[TBL] [Abstract][Full Text] [Related]
11. Inducibility of cytochromes P-450 by dioxin in liver and extrahepatic tissues of the marmoset monkey (Callithrix jacchus).
Schulz TG; Neubert D; Davies DS; Edwards RJ
Biochim Biophys Acta; 1996 Nov; 1298(1):131-40. PubMed ID: 8948497
[TBL] [Abstract][Full Text] [Related]
12. Comparison between cytochrome P450 (CYP) content and relative activity approaches to scaling from cDNA-expressed CYPs to human liver microsomes: ratios of accessory proteins as sources of discrepancies between the approaches.
Venkatakrishnan K; von Moltke LL; Court MH; Harmatz JS; Crespi CL; Greenblatt DJ
Drug Metab Dispos; 2000 Dec; 28(12):1493-504. PubMed ID: 11095589
[TBL] [Abstract][Full Text] [Related]
13. Caffeine, estradiol, and progesterone interact with human CYP1A1 and CYP1A2. Evidence from cDNA-directed expression in Saccharomyces cerevisiae.
Eugster HP; Probst M; Würgler FE; Sengstag C
Drug Metab Dispos; 1993; 21(1):43-9. PubMed ID: 8095225
[TBL] [Abstract][Full Text] [Related]
14. Human cytochrome P-450 metabolism of retinals to retinoic acids.
Zhang QY; Dunbar D; Kaminsky L
Drug Metab Dispos; 2000 Mar; 28(3):292-7. PubMed ID: 10681373
[TBL] [Abstract][Full Text] [Related]
15. Catalytic and immunochemical characterization of hepatic microsomal cytochromes P450 in beluga whale (Delphinapterus leucas).
White RD; Hahn ME; Lockhart WL; Stegeman JJ
Toxicol Appl Pharmacol; 1994 May; 126(1):45-57. PubMed ID: 8184432
[TBL] [Abstract][Full Text] [Related]
16. Cyp1a2 protects against reactive oxygen production in mouse liver microsomes.
Shertzer HG; Clay CD; Genter MB; Schneider SN; Nebert DW; Dalton TP
Free Radic Biol Med; 2004 Mar; 36(5):605-17. PubMed ID: 14980704
[TBL] [Abstract][Full Text] [Related]
17. Sequencing and characterization of mixed function monooxygenase genes CYP1A1 and CYP1A2 of Mink (Mustela vison) to facilitate study of dioxin-like compounds.
Zhang X; Moore JN; Newsted JL; Hecker M; Zwiernik MJ; Jones PD; Bursian SJ; Giesy JP
Toxicol Appl Pharmacol; 2009 Feb; 234(3):306-13. PubMed ID: 19041884
[TBL] [Abstract][Full Text] [Related]
18. Isozyme- and species-specific susceptibility of cDNA-expressed CYP1A P-450s to different flavonoids.
Tsyrlov IB; Mikhailenko VM; Gelboin HV
Biochim Biophys Acta; 1994 Apr; 1205(2):325-35. PubMed ID: 8155716
[TBL] [Abstract][Full Text] [Related]
19. Effect of beta-naphthoflavone on AhR-regulated genes (CYP1A1, 1A2, 1B1, 2S1, Nrf2, and GST) and antioxidant enzymes in various brain regions of pig.
Nannelli A; Rossignolo F; Tolando R; Rossato P; Longo V; Gervasi PG
Toxicology; 2009 Nov; 265(3):69-79. PubMed ID: 19786062
[TBL] [Abstract][Full Text] [Related]
20. The metabolism of the piperazine-type phenothiazine neuroleptic perazine by the human cytochrome P-450 isoenzymes.
Wójcikowski J; Pichard-Garcia L; Maurel P; Daniel WA
Eur Neuropsychopharmacol; 2004 May; 14(3):199-208. PubMed ID: 15056479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
